Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


15 enero 2015

AMERICAN JOURNAL OF NEURORADIOLOGY. Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course

T.R. Miller, R. Shivashankar, M. Mossa-Basha and D. Gandhi

SUMMARY: Reversible cerebral vasoconstriction syndrome is a clinical and radiologic syndrome that represents a common presentation of a diverse group of disorders. The syndrome is characterized by thunderclap headache and reversible vasoconstriction of cerebral arteries, which can either be spontaneous or related to an exogenous trigger. The pathophysiology of reversible cerebral vasoconstriction syndrome is unknown, though alterations in cerebral vascular tone are thought to be a key underlying mechanism. The syndrome typically follows a benign course; however, reversible cerebral vasoconstriction syndrome may result in permanent disability or death in a small minority of patients secondary to complications such as ischemic stroke or intracranial hemorrhage.

14 mayo 2015

AMERICAN JOURNAL OF NEURORADIOLOGY. Evaluating CT Perfusion Deficits in Global Cerebral Edema after Aneurysmal Subarachnoid Hemorrhage

H. Baradaran, V. Fodera, D. Mir, K. Kesavobhotla, J. Ivanidze, U. Ozbek, A. Gupta, J. Claassen and P.C. Sanelli

BACKGROUND AND PURPOSE: Global cerebral edema is an independent predictor of mortality and poor outcomes after aneurysmal SAH. Global cerebral edema, a complex disease process, is thought to be associated with an altered cerebral autoregulatory response. We studied the association between cerebral hemodynamics and early global cerebral edema by using CTP.

14 mayo 2015

AMERICAN JOURNAL OF NEURORADIOLOGY. Hyperintense Vessels on FLAIR: Hemodynamic Correlates and Response to Thrombolysis

A. Kufner, I. Galinovic, V. Ambrosi, C.H. Nolte, M. Endres, J.B. Fiebach and M. Ebinger

BACKGROUND AND PURPOSE: Hyperintense vessels on baseline FLAIR MR imaging of patients with ischemic stroke have been linked to leptomeningeal collateralization, yet the ability of these to maintain viable ischemic tissue remains unclear. We investigated whether hyperintense vessels on FLAIR are associated with the severity of hypoperfusion and response to thrombolysis in patients treated with intravenous tissue-plasminogen activator.

18 junio 2015

AMERICAN JOURNAL OF NEURORADIOLOGY. Periventricular Location as a Risk Factor for Hemorrhage and Severe Clinical Presentation in Pediatric Patients with Untreated Brain Arteriovenous Malformations

L. Ma, Z. Huang, X.-L. Chen, J. Ma, X.-J. Liu, H. Wang, X. Ye, S.-L. Wang, Y. Cao, S. Wang, Y.-L. Zhao and J.-Z. Zhao

BACKGROUND AND PURPOSE: The morphologic features of brain arteriovenous malformations differ between children and adults; therefore, our aim was to analyze various features of brain arteriovenous malformations to assess the risk of hemorrhage in children.

05 marzo 2015

AMERICAN JOURNAL OF NEURORADIOLOGY. MR Imaging–Detected Carotid Plaque Hemorrhage Is Stable for 2 Years and a Marker for Stenosis Progression

R.J. Simpson, S. Akwei, A.A. Hosseini, S.T. MacSweeney, D.P. Auer and N. Altaf

BACKGROUND AND PURPOSE: MR imaging–detected carotid plaque hemorrhage is associated with an increased risk of recurrent ischemic cerebrovascular events and could be an indicator of disease progression; however, there are limited data regarding the dynamics of the MR imaging–detected carotid plaque hemorrhage signal. We assessed the temporal change of this signal and its impact on carotid disease progression.

26 febrero 2015

AMERICAN JOURNAL OF NEURORADIOLOGY. Evaluation of 4D Vascular Flow and Tissue Perfusion in Cerebral Arteriovenous Malformations: Influence of Spetzler-Martin Grade, Clinical Presentation, and AVM Risk Factors

C. Wu, S.A. Ansari, A.R. Honarmand, P. Vakil, M.C. Hurley, B.R. Bendok, J. Carr, T.J. Carroll and M. Markl

BACKGROUND AND PURPOSE: The role of intracranial hemodynamics in the pathophysiology and risk stratification of brain AVMs remains poorly understood. The purpose of this study was to assess the influence of Spetzler-Martin grade, clinical history, and risk factors on vascular flow and tissue perfusion in cerebral AVMs.

23 abril 2015

AMERICAN JOURNAL OF NEURORADIOLOGY. Statin Therapy Does Not Affect the Radiographic and Clinical Profile of Patients with TIA and Minor Stroke

N. Asdaghi, J.I. Coulter, J. Modi, M.C. Camden, A. Qazi, M. Goyal, T. Rundek and S.B. Coutts

BACKGROUND AND PURPOSE: Acute statin therapy improves neurologic outcome and diminishes infarct growth in animal models of stroke. Clinical studies suggest that premorbid and early statin use is associated with improved outcome after major stroke. We studied the association between statin therapy and radiographic and clinical outcomes in patients with high-risk TIA and minor stroke.

19 febrero 2015

AMERICAN JOURNAL OF NEURORADIOLOGY. Fast Contrast-Enhanced 4D MRA and 4D Flow MRI Using Constrained Reconstruction (HYPRFlow): Potential Applications for Brain Arteriovenous Malformations

W. Chang, Y. Wu, K. Johnson, M. Loecher, O. Wieben, M. Edjlali, C. Oppenheim, P. Roca, J. Hald, B. Aagaard-Kienitz, D. Niemann, C. Mistretta and P. Turski

BACKGROUND AND PURPOSE: HYPRFlow is a novel imaging strategy that provides fast, high-resolution contrast-enhanced time-resolved images and measurement of the velocity of the entire cerebrovascular system. Our hypothesis was that the images obtained with this strategy are of adequate diagnostic image quality to delineate the major components of AVMs.

01 junio 2015

NEUROSURGERY. Clinical Outcome of Children With Suspected Shunt Malfunction Evaluated in the Emergency Department

Sribnick, Eric MD, PhD*,‡,§; Sarda, Samir BS*,‡; Moore, Mike MD§; Capasse, Meredith BS‡; Tubbs, R. Shane MS, PA-C, PhD¶; Wrubel, David MD‡,§; Chern, Joshua J. MD, PhD‡,§

BACKGROUND: Patients with cerebrospinal fluid shunts frequently present to the emergency department (ED) with suspected shunt malfunction. The outcome of those patients who were discharged from ED when shunt malfunction was deemed unlikely has not been previously documented.

06 agosto 2015

STROKE. Clinical Sciences. Cost-Utility Analysis of Mechanical Thrombectomy Using Stent Retrievers in Acute Ischemic Stroke

Jeban Ganesalingam, MBBS, MRCP (Neuro), PhD*; Elena Pizzo, PhD*; Stephen Morris, PhD; Tom Sunderland, MSc; Diane Ames, MBBS, FRCP; Kyriakos Lobotesis, MBBS, FRCR

Background and Purpose: Recently, 5 randomized controlled trials demonstrated the benefit of endovascular therapy compared with intravenous tissue-type plasminogen activator in acute stroke. Economic evidence evaluating stent retrievers is limited. We compared the cost-effectiveness of intravenous tissue-type plasminogen activator alone versus mechanical thrombectomy and intravenous tissue-type plasminogen activator as a bridging therapy in eligible patients in the UK National Health Service.

06 agosto 2015

STROKE. Clinical Sciences. Intracranial Carotid Calcification on Cranial Computed Tomography. Visual Scoring Methods, Semiautomated Scores, and Volume Measurements in Patients With Stroke

Deepak Subedi, FRCR; Umme Sara Zishan, MBBS; Francesca Chappell, PhD; Maria-Lena Gregoriades, FRCR; Cathie Sudlow, DPhil; Robin Sellar, FRCR; Joanna Wardlaw, FRCR, MD

Background and Purpose: Intracranial internal carotid artery calcification is associated with cerebrovascular risk factors and stroke, but few quantification methods are available. We tested the reliability of visual scoring, semiautomated Agatston score, and calcium volume measurement in patients with recent stroke.

22 julio 2014

STROKE. Clinical Sciences. Flow Diversion Versus Conventional Treatment for Carotid Cavernous Aneurysms

Mario Zanaty, MD; Nohra Chalouhi, MD; Robert M. Starke, MD; Guilherme Barros, BS; Mark Philip Saigh, BA; Eric Winthrop Schwartz, BS; Norman Ajiboye, MD; Stavropoula I. Tjoumakaris, MD; David Hasan, MD; Robert H. Rosenwasser, MD; Pascal Jabbour, MD

Background and Purpose: Several endovascular treatment options are available for cavernous carotid aneurysms. We compared pipeline embolization device (PED) versus conventional endovascular treatment in terms of evolution of mass effect, complications, recurrence, and retreatment rate

31 julio 2014

STROKE. Clinical Sciences. Long-Term Follow-Up Study of Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis Trial

Jean-Louis Mas, MD; Caroline Arquizan, MD; David Calvet, PhD; Alain Viguier, MD; Jean-François Albucher, MD; Philippe Piquet, MD; Pierre Garnier, MD; Fausto Viader, MD; Maurice Giroud, MD; Hassan Hosseini, PhD; Grégoire Hinzelin, MD; Pascal Favrole, MD; Hilde Hénon, MD; Jean-Philippe Neau, MD; Xavier Ducrocq, MD; Raymond Padovani, MD; Loic Milandre, MD†; François Rouanet, MD; Valérie Wolff, MD; Denis Saudeau, MD; Marie-Hélène Mahagne, MD; Denis Sablot, MD; Pierre Amarenco, MD; Vincent Larrue, MD; Bernard Beyssen, MD; Didier Leys, PhD; Thierry Moulin, MD; Michel Lièvre, MD; Gilles Chatellier, MD; on behalf of the EVA-3S Investigators

Background and Purpose: We aimed at comparing the long-term benefit–risk balance of carotid stenting versus endarterectomy for symptomatic carotid stenosis.

29 julio 2014

STROKE. Clinical Sciences. Thrombolysis in Ischemic Stroke Without Arterial Occlusion at Presentation

Sourabh Lahoti, MD; Sankalp Gokhale, MD; Louis Caplan, MD; Patrik Michel, MD; Yves Samson, MD; Charlotte Rosso, MD, PhD; Kaustubh Limaye, MD; Archana Hinduja, MD; Aneesh Singhal, MD; Syed Ali, MD; Luther Creed Pettigrew, MD; Richard Kryscio, PhD; Nikita Dedhia, MD; Shirish Hastak, MD, DM; David S. Liebeskind, MD

Background and Purpose: None of the randomized trials of intravenous tissue-type plasminogen activator reported vascular imaging acquired before thrombolysis. Efficacy of tissue-type plasminogen activator in stroke without arterial occlusion on vascular imaging remains unknown and speculative.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.